The thing to remember about Blis is that it is an alternative to antibiotics in some situations.
"Dr Chan said we could be entering into a “post-antibiotic era”...“Things as common as strep throat or a child’s scratched knee could once again kill." http://www.telegraph.co.uk/health/he...WHO-claim.html
"Already 25,000 Europeans die every year from antibiotic-resistant infections," http://www.telegraph.co.uk/health/he...tibiotics.html
Blis is a fantastic discovery for mankind. It already saves much suffering amongst people who use it, and I have no doubt it will save lives in future as antibiotics become more feeble. The strep throat is one example, surely.
I don't know what the future is for BLT any more than anyone else, but I think it most likely the product itself will certainly survive now. All we're arguing about is how much that might profit the existing shareholders now.
If the product survives, I will be immensely pleased to have played a small part in launching that into the world through providing money to the company promoting it. This product is such a very significant discovery that I will always count my very small contribution to that as nevertheless something I will be proud of for the rest of my life.
From the low response of shareholders to the last issue, I have to assume that very many people have not considered the enormity of this discovery for mankind. Sounds melodramatic, I know, but actually it's true.